We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Artificial Intelligence Helps Identify T-cell Targets for Development of SARS-CoV-2 Vaccine

By HospiMedica International staff writers
Posted on 10 Jul 2020
Print article
Illustration
Illustration
A neoantigen prediction platform that employs state-of-the-art bioinformatics and artificial intelligence (AI) to identify an optimal set of neoantigens as targets for cancer vaccines or adoptive cell therapies is being used for the development of a SARS-CoV-2 vaccine.

The neoantigen prediction platform called ArdImmune Vax has been developed by Ardigen (Kraków, Poland) and is very well suited for the design of vaccines for infectious diseases. The core of the platform is a proprietary algorithm capable of predicting neoantigens' probability to elicit an immune response.

ArdImmune has now entered into a research collaboration with COVID-19 Vaccine Corporation (CVC Auckland; New Zealand) aimed at the development of SARS-CoV-2 vaccine. The joint research enables CVC to benefit from Ardigen's vaccine design technology by selecting which viral epitopes are the most suitable to boost cellular immune response. Complementing humoral and cellular response in the vaccine design is expected to result in two strong lines of defense against the coronavirus. This approach is likely to be more effective than vaccines designed to create antibodies alone.

"We are thrilled to help global efforts to mitigate COVID-19 applying our breakthrough technology powered by artificial intelligence, reducing the vaccine design phase to a few weeks," said Janusz Homa, CEO of Ardigen.

"CVC is excited to be working with Ardigen who are at the forefront of T-cell epitope design. The collaboration gives us the best chance of our product inducing an effective T-cell response against SARS-Cov-2," said Robert Feldman, CEO and Co-founder of CVC.

Related Links:
Ardigen
COVID-19 Vaccine Corporation


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Forceps
BiClamp LAP

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.